Li Zhu is a seasoned professional in the field of biostatistics and data science. With a Ph.D. in Statistics from the University of California, Davis, Zhu has held various roles at reputable companies such as Amgen, Biogen, and currently at Pharvaris. Zhu's most recent position as Vice President and Head of Biometrics & Data Science at Pharvaris highlights their expertise and leadership in utilizing statistical analysis to drive strategic decision-making in the pharmaceutical industry.
Org chart
Teams
This person is not in any teams
Offices
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.
